Physical activity is key for people with rheumatoid arthritis
Rheumatoid arthritis (RA) is both bothersome and painful. Less well known is the risk of premature death, because the disease can contribute to a less healthy lifestyle.

Rheumatoid arthritis (RA) is both bothersome and painful. Less well known is the risk of premature death, because the disease can contribute to a less healthy lifestyle.
You may think that they’re random movements, but they’re not: The way you use your eyes when perceiving the world around you reveals something significant about you and how you engage with the world. It can even be a diagnostic of brain disease.
Flu season might be much worse than usual because we have lost a lot of herd immunity. Pandemic measures are part of the reason. Hand washing and vaccination are still important.
Even the toughest “soldiers” in our immune system are not tenacious enough to knock out cancerous tumours. NTNU professor Øyvind Halaas aims to do something about that.
After conducting the largest study on osteoarthritis in the world, researchers are now on track to develop a medicine that can slow it down.
Many people have been robbed of a very basic need during the pandemic: physical contact. Human touch triggers hormones like serotonin, dopamine and oxytocin. Hormones that make us feel good flourish when we touch each other.
An assessment tool can make it easier for healthcare professionals to identify pain in residents with dementia. The right treatment can improve residents’ quality of life.
For the first time, raw data on Norwegian coronavirus genes will be freely available through the open gene bank ENA.
These research scientists are studying Nature’s own nanomaterials – applying tools and methods that are normally used for something quite different. Their work has provided us with knowledge that may revolutionise everything from medical treatments to building constructions.
Several commonly prescribed medications used for completely different illnesses can enhance or reduce the activity of the influenza virus.
The University of Bergen and the Kavli Institute at NTNU are joining forces on brain research with support from the Trond Mohn Foundation.
The fight against COVID-19 is far from over. A new combination of drugs could help save lives.
A majority of employees in Norwegian nursing homes have committed abuse or neglect of the elderly, a comprehensive report shows.
Lybe Scientific, a start-up company based on NTNU research, is entering the market as a provider of high-quality diagnostic solutions – not just for COVID-19 diagnostics, but also other areas such as the common flu and sexually transmitted diseases.
An NTNU researcher has discovered what happens in the genes of divers with decompression sickness. The breakthrough is gaining international attention after more than a century of searching for the causes of divers’ disease.
Bacteria in wild bears become more resistant to antibiotics when human antibiotic use is high.
A psychiatrist’s study reviewed more than 200 rape cases and found that the most vulnerable women who were raped received the worst follow-up by the police.
A new invention may be on the verge of replacing a costly cranial surgical procedure currently being performed on some traffic accident victims and other patient groups. The ultrasound-based technology has now been granted CE approval for the European market.
Do you find it easier to remember exactly where something is located rather than remembering exactly what is there? In that case, your experience is in sync with NTNU brain researchers’ new findings about memory.
A tiny region in the middle of the brain plays a far more important role than previously known in helping it respond to changes in the environment, a new study shows.
For the first time, researchers have shown how cancer cells reprogram themselves to produce lactic acid and to tolerate the acidic environment that exists around tumours. The finding could lead to a whole new direction for treating cancer.
In neonatal medicine, there is a grey area where professionals may be uncertain whether it is in the child’s best interests to start life-saving treatment. Without it, the infant dies. But the treatment can also do great harm. One of the foremost duties of medicine is often said to be to “do no harm”. But how much of a burden on the infant is acceptable? At what point is the hope simply too small to justify action?
The cytotoxic drugs used in chemotherapy can themselves contribute to the cancer cells developing resistance to treatment.
Back pain is very common. But a new app called selfBACK can help us get better.